Economy/Home · Economy

[Breaking] HLB Group Stocks Mixed in Early Trading... HLB Pharmaceutical Surges 26%, HLB Innovation Weakens

HLB group stocks showed mixed movements by individual stock in early trading on the 29th. Following the previous day, the 28th, when they all closed at the upper limit, some stocks such as HLB Pharmaceutical and HLB Biostep recorded double-digit gains again today, drawing concentrated market attenti

Oseong Kwon
Staff Reporter
3 min read
[Breaking] HLB Group Stocks Mixed in Early Trading... HLB Pharmaceutical Surges 26%, HLB Innovation Weakens
CBC News

HLB group stocks showed mixed movements by individual stock in early trading on the 29th. Following the previous day, the 28th, when they all closed at the upper limit, some stocks such as HLB Pharmaceutical and HLB Biostep recorded double-digit gains again today, drawing concentrated market attention. HLB is also showing strength.

As of 9:02 a.m. on the 29th, HLB (028300) is trading at 45,250 won, up 13.97% from the previous trading day.

Among group affiliates, HLB Pharmaceutical's (047920) rise stands out. At the same time, HLB Pharmaceutical is up 26.29% from the previous trading day at 12,150 won. HLB Biostep (278650) is also continuing its strength, trading up 22.76% at 3,990 won.

In addition, HLB Therapeutics is trading up 13.37% at 2,925 won, and HLB Global is up 12.89% at 2,320 won. HLB PanZin is up 4.60% at 1,498 won. Meanwhile, HLB Innovation is trading down 7.92% at 18,120 won, showing weakness.

▶ Whether the strength will continue is a key point to watch

With gains varying across stocks within the group, whether the early strength will continue until the regular session close is a key point to watch. However, as some stock prices are moving sharply again today following the previous day's surge, investors should be mindful of short-term volatility.

In particular, attention is focused on how the group stocks will trend through the last trading day of September on the 30th.

[※ This article is intended for investment reference only and does not recommend buying or selling. Investment decisions and the resulting responsibility lie with the investor.]

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.